Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086265 · ClinicalTrials.gov registry record · NA
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03086265: Completed NA study, sponsored by Stanford University.
NCT03086265 is a NA study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03086265, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of high-flow oxygen through specialized nasal cannula: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).
Interventions
- DEVICE Endotracheal tube
- DEVICE THRIVE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2019-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03086265
The ClinicalTrials.gov registry entry for NCT03086265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endotracheal tube is the first listed.
NCT03086265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03086265 about?
NCT03086265 is a clinical study titled "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery". The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of ...
What is the current status of trial NCT03086265?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-03-24. Estimated completion is 2019-02-26.
What interventions are being tested in trial NCT03086265?
The interventions under investigation include: Endotracheal tube (DEVICE), THRIVE (DEVICE).
Who is sponsoring clinical trial NCT03086265?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.